Bartlett & Co’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$3K Sell
11
-309
-97% -$76.4K ﹤0.01% 1123
2023
Q3
$79K Buy
+320
New +$87.6K ﹤0.01% 575
2022
Q4
Sell
-6
Closed -$1K 1123
2022
Q3
$1K Sell
6
-5
-45% -$996 ﹤0.01% 1101
2022
Q2
$2K Buy
+11
New +$2.36K ﹤0.01% 1168
2021
Q4
Sell
-18
Closed -$4K 595
2021
Q3
$4K Buy
18
+1
+6% +$244 ﹤0.01% 791
2021
Q2
$4K Hold
17
﹤0.01% 778
2021
Q1
$3K Hold
17
﹤0.01% 831
2020
Q4
$3K Buy
+17
New +$2.49K ﹤0.01% 850
2019
Q3
Sell
-12
Closed -$2K 888
2019
Q2
$2K Buy
+12
New +$1.52K ﹤0.01% 674

Other funds holding HCA

Bartlett & Co's HCA Position: Q4 2023 in Review

Bartlett & Co reduced its HCA Healthcare (HCA) stake by 97% in Q4 2023, selling an estimated $76.4K and leaving 11 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1123.

Bartlett & Co first reported a position in HCA in Q2 2019 and has held it in 9 quarters since. The position peaked at $79K in Q3 2023. 1,056 funds tracked by Wall St. Rank hold HCA as of Q4 2023.

  • Bartlett & Co held 11 shares of HCA Healthcare worth $3K as of Q4 2023.
  • Bartlett & Co sold 309 HCA Healthcare shares in Q4 2023, an estimated $76.4K.
  • HCA Healthcare made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #1123 holding.
  • Bartlett & Co first reported a position in HCA Healthcare in Q2 2019 and has held it in 9 quarters since.
  • Bartlett & Co's HCA Healthcare position peaked at $79K in Q3 2023.
  • 1,056 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.